TechnoPhage, SA - From science to innovative biopharmaceuticals
A leading consortium of industrial partners has been awarded a grant by the Seventh Framework Program of the European Union for an innovative research and development project "TA101 GOCLIN: Clinical development of TA-101 for the treatment of rheumatoid arthritis" (#606352). The aim of this Project is to take TA101, a small domain antibody…
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage, Phage Peptides and Methods of Use Thereof Office: United States Patent and Trademark Office Date: 22/10/2013 Patent no: US 8,563,504 B2
New patent granted to TechnoPhage: Title: Engineered Rabbit Antibody Variable Domains and Uses Thereof Office: The Registry of Patents Singapore Date: 11/10/2013 Patent no: 156768 [WO 2008/136694]
TechnoPhage invited to present Rheumatoid Arthritis therapeutics development programme at National Association of Rheumatoid Arthritis Patients (ANDAR) Symposium - "Disclosing the future in RA: the Portuguese contribution" at Gulbenkian Foundation, Lisboa, Portugal.

2019 events

Phage Futures Europe
Brussels, Belgium, September 25-26, 2019